Notice of Intent to Sole Source: vSpot Spectrum

Closed Pre-Solicitation Posted

Solicitation number
75D30124Q78255
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Atlanta, Georgia, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Centers for Disease Control and Prevention (CDC) intends to award a sole source contract to AID Autoimmun Diagnostika GmbH for one (1) AID vSpot Spectrum, an EliSpot/FluoroSpot device capable of detecting viral colonies in various plate formats. The new system must comply with CDC's quality management requirements and meet specific technical specifications, including the ability to test samples in multiple well formats, perform colony counting, and use a single user interface. Interested parties may submit responses by August 29, 2024, demonstrating their capability to provide a product meeting the stated requirements.

This is a non-set-aside contract action, and AID Autoimmun Diagnostika GmbH is the only known source capable of fulfilling the requirement. No additional details on award value or budget range are provided. The contract will include two years of technical support and software upgrades at no additional charge.

Notice text

The Centers for Disease Control and Prevention intends to award a sole source contract to AID Autoimmun Diagnostika GmbH (Ebinger Str. 4 D-72479 Strassberg) for one (1) AID vSpot Spectrum.

CDC has a requirement for an EliSpot/FluoroSpot device that is capable of detecting viral colonies in different plate formats including 6-, 12-, 24-, 48-, 96- and 384-well plates. The new system must be able to read both colorimetric and fluorescent spots with 7&1 filter wheel allowing for customized selection of up to 7 individual narrow bands & hard-coated fluorescent filters while analyzing enzymatic activities on various plate formats. The new system must be able to fit into a small bench top
space of 430x430x550 mm. The new system must be able to comply with CDC's Quality Management System requirements.
The AID vSpot Spectrum is the high-end EliSpot/FluoroSpot device that meets all the above required specifications.

This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b)(1). AID Autoimmun Diagnostika GmbH is the only source capable of fulfilling this requirement.  Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations / responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any response should be emailed to contract specialist at ttu3@cdc.gov. Questions or responses will not be accepted by phone.

Any quotation in response to this notice must indicate the capability to provide a product that includes the below technical specifications:

  1. Can test samples in 6-well, 12-well, 24-well, 48-well and 96-well formats for enzymatic assays
  2. Can perform colony counting in 6-well, 12-well and 48-well formats for viral plaque assay
  3. Must include 3 fluorescence filters (FITC, Cy3 and Cy5) to read and count 3 fluorescent spots in 96-well format with the choice of up to 7 different colors
  4. Must include at least 3 narrowband optical filters to prevent crosstalk or overlapping of excitation and emission wavelengths for 3 fluorescent dyes
  5. Use single graphic user interface for analyzing different plate formats to minimize run time for improved throughput.
  6. 43 cm x 43 cm x 55 cm or smaller

The quote must also provide for a two-year technical support and software upgrade at no additional charge.

Similar open opportunities

Opportunity Agency Set-aside Responses due
Notice of Intent to Sole Source a Thermo Orbitrap Fusion Lumos and Thermo RSLCnano UPLC Maintenance Agreement Georgia 30329, United States · NAICS 811210 CDC Office of Acquisition Services No set-aside
1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC) Bethesda, Maryland 20892, United States · NAICS 811210 National Institute of Allergy and Infectious Diseases No set-aside
Notice of Intent to Sole Source – AB Sciex LLC Maryland 20892, United States · NAICS 339112 NIH Clinical Center No set-aside
Notice of Award Maintenance for Government owned BacT/ALERT 3D Equipment. Medical Command No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity